Key Points
- Perioperative hypothermia is usually defined as core temperature below 36°C.
- Anesthesia causes redistribution of core heat and impairs normal thermoregulation.
- Prewarming can reduce the initial redistribution drop in temperature.
- Forced-air warming is a core preventive strategy for patients at risk.
- Warm larger-volume IV fluids and blood products rather than infusing them at room temperature.
- Temperature monitoring should be continuous or frequent enough to identify a downward trend early.
- Hypothermia increases bleeding, transfusion risk, shivering, delayed drug recovery, and postoperative complications.
- Persistent hypothermia despite warming should prompt evaluation for ongoing heat loss or illness.
- Continue warming in PACU until normothermia and comfort are restored.
Algorithm
- Measure preoperative temperature and identify hypothermia risk factors.
- Prewarm high-risk patients when feasible before induction.
- Minimize skin exposure and initiate active forced-air warming for appropriate cases.
- Monitor core or validated near-core temperature through the procedure.
- Warm IV fluids of clinically significant volume and blood products using an approved device.
- If temperature falls, verify warming-device function and identify ongoing sources of heat loss.
- Escalate warming and investigate hemorrhage, sepsis, endocrine disease, or other pathology if hypothermia is disproportionate.
- Continue active warming and temperature monitoring in recovery until clinically normothermic.
Clinical Synopsis & Reasoning
General and neuraxial anesthesia impair thermoregulatory vasoconstriction and shivering, allowing rapid redistribution of heat from the core to the peripheral compartment after induction. Continued heat loss occurs through radiation, convection, evaporation, conduction, cold IV fluids, and exposure of large surgical surfaces. A patient can therefore become hypothermic even in a room that feels warm to staff.
Risk increases with older age, frailty, low body mass, low preoperative temperature, major or long-duration surgery, large exposed body surface, major fluid shifts, cold operating rooms, burns, trauma, endocrine disease, sepsis, and combined general and neuraxial anesthesia. A preoperative temperature below 36°C should prompt active warming and reconsideration of proceeding with nonurgent anesthesia until temperature improves when clinically appropriate.
Core or near-core temperature should be measured with a site and device appropriate to the procedure. Esophageal, nasopharyngeal, bladder, and other validated methods differ in response time and suitability. Peripheral skin measurements can be misleading. Temperature should be incorporated into the anesthesia record and monitored throughout procedures in which clinically significant temperature change is possible.
Hypothermia is not simply a comfort problem. It impairs platelet function and coagulation enzyme activity, increases surgical bleeding and transfusion risk, promotes shivering and oxygen consumption, alters drug metabolism and neuromuscular recovery, delays anesthetic emergence, and is associated with wound complications. Prevention is more effective than trying to rewarm a profoundly cold patient at the end of surgery.
Treatment Strategy & Disposition
Prewarm high-risk patients when feasible, particularly before induction, to reduce redistribution hypothermia. Cover exposed skin and minimize unnecessary exposure. Use active forced-air warming during procedures at meaningful risk of hypothermia rather than relying only on passive blankets. Adjust the device to avoid thermal injury and keep the warming system away from compromised skin or areas where pressure and perfusion are impaired.
Warm IV fluids when clinically significant volumes are infused. NICE guidance specifically recommends warming IV fluids of 500 mL or more and blood products to approximately 37°C using a fluid-warming device. Irrigation fluids used in large volumes should also be warmed when appropriate. Fluid warming alone does not replace active patient warming because radiation and redistribution are major sources of heat loss.
Measure temperature at regular intervals and respond to downward trends before the patient crosses 36°C. If temperature remains low despite warming, assess device function, exposure, ongoing cold-fluid administration, hemorrhage, sepsis, endocrine disease, or environmental factors. Severe hypothermia requires a broader resuscitation strategy and is not managed as routine perioperative cooling.
In PACU, continue active warming if temperature remains below target or the patient is shivering and uncomfortable. Treat pain and nausea, because shivering can worsen discomfort and metabolic demand. Meperidine can reduce shivering but has opioid adverse effects; alternative strategies include warming and selected nonopioid agents according to local practice. Confirm adequate neuromuscular recovery because hypothermia can prolong blockade.
Epidemiology / Risk Factors
- Inadvertent hypothermia remains common without systematic prevention.
- Longer surgery, major surgery, older age, low starting temperature, and large fluid administration increase risk.
- Active warming programs have made perioperative normothermia a standard quality target.
- Many hypothermia complications are preventable with prewarming, active warming, and warmed fluids.
Investigations
| Test | Role / Rationale | Typical Findings | Notes |
|---|---|---|---|
| Core temperature monitoring | Detects and trends perioperative heat loss | Temperature below 36°C indicates hypothermia | Use validated measurement site |
| Hemoglobin | Evaluates occult or ongoing bleeding | Falling hemoglobin in hemorrhage | Check when hypothermia accompanies hemodynamic change |
| Blood gas | Assesses acid-base and perfusion in severe illness | Acidosis or lactate elevation | Not needed for uncomplicated mild hypothermia |
| Glucose | Identifies hypoglycemia as contributor | Low glucose | Useful with unexplained altered mental status |
| Thyroid testing | Evaluates severe unexplained hypothyroid state | Elevated TSH/low free T4 in primary hypothyroidism | Not routine for ordinary perioperative cooling |
| Coagulation studies | Assesses bleeding/coagulopathy | May be abnormal in major hemorrhage | Clinical coagulopathy can occur even when standard labs underrepresent temperature effect |
Benefits of Normothermia
| Outcome | Effect |
|---|---|
| Surgical-site infection | Maintaining normothermia is associated with lower wound complication risk |
| Bleeding and transfusion | Hypothermia impairs hemostasis and can increase blood loss |
| Cardiac stress | Shivering and sympathetic activation increase oxygen demand |
| Drug recovery | Hypothermia slows metabolism and neuromuscular recovery |
| PACU duration | Normothermia supports timely emergence and discharge |
| Patient comfort | Active warming reduces cold discomfort and shivering |
Pharmacology
| Medication | Mechanism | Onset | Role in Therapy | Limitations |
|---|---|---|---|---|
| Meperidine | Opioid with anti-shivering properties | Minutes | Selected treatment for significant postoperative shivering | Respiratory depression, sedation, serotonergic and metabolite concerns |
| Dexmedetomidine | Alpha-2 agonist | Minutes | Can reduce shivering in selected settings | Bradycardia and hypotension |
| Clonidine | Alpha-2 agonist | Hours | Occasional anti-shivering adjunct | Hypotension and sedation |
| Neuromuscular blockers | Block skeletal muscle nicotinic receptors | Minutes | Facilitate surgery and ventilation | Effects can be prolonged by hypothermia |
| Volatile anesthetics | General anesthetic agents | Minutes | Maintain anesthesia | Impair thermoregulation and contribute to redistribution |
Prognosis / Complications
- Most mild perioperative hypothermia resolves with active warming and causes no permanent harm.
- Greater depth and duration of hypothermia increase bleeding, delayed recovery, and cardiopulmonary stress.
- Maintaining normothermia is associated with improved recovery and fewer preventable complications.
- Persistent unexplained hypothermia requires evaluation rather than indefinite warming alone.
Patient Education / Counseling
- Tell high-risk patients that warming devices are used to prevent complications as well as improve comfort.
- Explain that the patient may continue active warming in recovery if temperature remains low.
- Patients with previous severe perioperative hypothermia should tell future anesthesia teams.
- Advise patients to report symptoms of infection or endocrine disease when hypothermia was unexpected.
- Clarify that warming blankets and devices are normal parts of modern perioperative safety.
Notes
Preventing hypothermia works best as a system rather than an individual rescue maneuver. Preoperative temperature, active warming equipment, fluid warmers, documentation, and PACU handoff should all be built into routine workflow.
A low temperature in the operating room may be expected after long exposure, but it should never be automatically dismissed. The clinical context determines whether warming alone is sufficient or whether hypothermia is a sign of hemorrhage, infection, endocrine disease, or another physiologic problem.
References
- NICE CG65: Hypothermia Prevention and Management in Adults Having Surgery — Link
- NICE CG65 Recommendations — Link
Turn pharmacology review into vignette practice.
Most students do not plateau because they refuse to study. They plateau because their review does not show the exact reasoning error behind repeated misses. MDSteps turns topic review into targeted blocks, explanations, flashcards, and readiness signals.
- Full access to 1,100+ medical reference articles linked directly to relevant QBank concepts
- 16,000+ USMLE-style questions across Step 1, Step 2 CK, and Step 3
- Depth-on-Demand™ explanations that isolate the pivot clue, distractor trap, and decision point
- CCS cases with live vitals, order timing, reassessment, and after-action feedback